当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Design, Synthesis, and Pharmacological Evaluation of Biaryl-Containing PD-1/PD-L1 Interaction Inhibitors Bearing a Unique Difluoromethyleneoxy Linkage
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2021-11-11 , DOI: 10.1021/acs.jmedchem.1c01422
Zilan Song 1, 2, 3, 4 , Bo Liu 2 , Xia Peng 3 , Wangting Gu 1 , Yiming Sun 2 , Li Xing 1 , Yi Xu 5 , Meiyu Geng 2, 3, 4 , Jing Ai 2, 4 , Ao Zhang 1, 2, 3, 4, 6
Affiliation  

Blockade of immune checkpoint PD-1/PD-L1 has been a promising anticancer strategy; however, clinically available PD-1/PD-L1 small-molecule inhibitors are lacking. In view of the high potency of compound 2 (BMS-1002), structural fine tuning of the methoxy linkage together with diverse modification in the solvent interaction region was conducted. A series of novel derivatives featuring a difluoromethyleneoxy linkage were designed. Compound 43 was identified as the most promising PD-1/PD-L1 inhibitor with an IC50 value of 10.2 nM in the HTRF assay. This compound is capable of promoting CD8+ T cell activation through inhibiting PD-1/PD-L1 cellular signaling. Moreover, in the Hepa1-6 syngeneic mouse model, administration of compound 43 at 1 mg/kg dosage promoted CD8+ T cell activation and delayed the tumor growth with good tolerance. Notably, the tumor in one mouse of the compound 43-treated group was completely regressed. These results indicate that compound 43 is a promising candidate worthy of further investigation.

中文翻译:

具有独特二氟亚甲氧基键的含联芳基 PD-1/PD-L1 相互作用抑制剂的设计、合成和药理学评价

阻断免疫检查点PD-1/PD-L1一直是一种很有前景的抗癌策略;然而,缺乏临床可用的PD-1/PD-L1小分子抑制剂。鉴于化合物2 (BMS-1002) 的高效力,进行了甲氧基键的结构微调以及溶剂相互作用区域的多种修饰。设计了一系列具有二氟亚甲氧基键的新型衍生物。化合物43被鉴定为最有希望的 PD-1/PD-L1 抑制剂,在 HTRF 测定中其 IC 50值为 10.2 nM。该化合物能够通过抑制 PD-1/PD-L1 细胞信号传导来促进 CD8 + T 细胞活化。此外,在 Hepa1-6 同系小鼠模型中,给予化合物43在 1 mg/kg 剂量下促进 CD8 + T 细胞活化并以良好的耐受性延缓肿瘤生长。值得注意的是,化合物43治疗组的一只小鼠中的肿瘤完全消退。这些结果表明化合物43是一种有前途的候选物,值得进一步研究。
更新日期:2021-11-25
down
wechat
bug